By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Personalized medicine software startup Intervention Insights of Grand Rapids, Mich., has reeled in $7.2 million in Series B financing, which it plans to use to expand its commercialization efforts, venture capital firm Beringea said Tuesday.

Led by Mich.-based Beringea, the funding round also included investments from Chrysalis Ventures, Hope Life Sciences, the Michigan Accelerator Fund, and other existing investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."